stars 1 stars 2 stars 3

We are a clinical stage protein manipulation company creating new therapeutics for patients worldwide. Our platform technologies consist of: - Protein-protein interaction blockade which prevents specific disease-causing proteins from interacting with each other; - Protein degradation which harnesses the body's own natural processes to destroy disease causing proteins. By adopting these approaches, we are expanding the scope of new targets for drug development and unlocking the untapped pool of targets that to date have been considered undruggable. Our goal is to develop a new generation of therapeutics for patients that currently have few options, if any, to treat their diseases effectively.

Primary Peptides Questions

The Primary Peptides annual revenue was $5 million in 2026.

Julie Rezler is the VP Corporate Development of Primary Peptides.

3 people are employed at Primary Peptides.

Primary Peptides is based in Vancouver, British Columbia.

The NAICS codes for Primary Peptides are [32541, 3254, 325, 32].

The SIC codes for Primary Peptides are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users